About 36% of the tumor genome had copy number changes in the CR gene loss TP53 mutant cohort, while only 13% was altered in TP53 mutant tumors without CR losses (p< 0.01 by Wilcoxon rank-sum test) (Fig 5C). The gene discussed is TP53; the disease is neoplasm.